Stefan Kirov

Stefan is a seasoned omics expert, specializing in evolutionary cancer biology. His current focus is on the analysis of human cancer genetics and other omics data, in order to improve drug development outcomes.

Previously at Servier, Stefan built an exploratory biology concept based on an evolutionary approach to human cancer genetics data. Prior to that, he formed the NGS group and platform from the ground up at Bristol Myers Squibb.